Donald Leung is a Rheumatology/Immunology physician affiliated with National Jewish Health. OpenAlex indexes 1,213 publications with 70,890 citations (h-index 135); ClinicalTrials.gov lists 18 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Allergy & Immunology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Jackson St
Denver, CO 802062761
Telephone
303-388-4461Provider last certified this registry record 12 Nov 2020.
Clinical trials
- Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Skin Barrier Assessment in Pregnancy and at Birth
Sponsor: National Jewish Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202518 payments$43,145openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- Genentech, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
15 NIH research awards on record, funded 1990–2026 per NIH RePORTER. The latest:
- ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER
National Jewish Health
FY2026$4,361,109UM1AI151958 - ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER
National Jewish Health
FY2026$330,358U01AI152037 - ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER
National Jewish Health
FY2025$4,349,476UM1AI151958
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immune checkpoint inhibitor–related dermatologic adverse events
Journal of the American Academy of Dermatology
2020 - Significance of Skin Barrier Dysfunction in Atopic Dermatitis
Allergy Asthma and Immunology Research
2018 - Antimicrobials from human skin commensal bacteria protect against <i>Staphylococcus aureus</i> and are deficient in atopic dermatitis
Science Translational Medicine
2017
Similar KOLs
Other experts from the same institution or the same specialty.
James Crapo, MD
National Jewish Health
Barry Make, MD
National Jewish Health
Charles Daley, MD
National Jewish Health
Jeffrey Swigris, DO
National Jewish Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”